This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Quarter ended Sep 2026 consolidated profit after tax was Rs 21.66 lakh vs Rs 8.30 lakh in Sep 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 1.1 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Consolidated profit after tax was Rs 21.66 lakh in the quarter ended September 30, 2026, versus Rs 8.30 lakh in the quarter ended September 30, 2025; revenue from operations was nil in both. Hospital business was sold; no operations remain, and restructuring is under review. Auditor highlighted Rs 3,426.39 lakh cash support for obligations and did not change its review. Consolidated six-month operating cash outflow was Rs 160.68 lakh.
Quarterly profit rose 161% from a low base, but no revenue and continued cash use leave the company's future highly uncertain.
The company's XBRL figures for this quarter look filed in the wrong unit: revenue reads ₹0.18 Cr against ₹0.03 Cr a year ago, about 7× larger. A move that size is almost always a wrong unit, not a business, so nothing is computed from these figures and no number-based tags are set; the read above is the AI's, from the document.